NAYA Biosciences Investor Relations Material
Latest events
Status Update
NAYA Biosciences
Q1 2025
21 May, 2025
Q4 2024
30 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from NAYA Biosciences Inc
Access all reports
INVO Bioscience Inc develops and markets medical technologies for the treatment of infertility. The company offers devices and solutions designed to enable in vivo fertilization as an alternative to traditional in vitro fertilization procedures. INVO Bioscience operates within the healthcare and medical technology sectors. The company is headquartered in Sarasota, Florida, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
NAYA
Country
🇺🇸 United States